The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

SkinBioTherapeutics signs agreement with Winclove Probiotics to develop psoriasis food supplement
Biotics and Supplements

SkinBioTherapeutics signs agreement with Winclove Probiotics to develop psoriasis food supplement

FEB 24, 2020
DuPont Nutrition & Biosciences Enters into Collaboration with Microbiome Specialist MRM Health
Finance

DuPont Nutrition & Biosciences Enters into Collaboration with Microbiome Specialist MRM Health

FEB 20, 2020
Da Volterra announces positive Phase 2 results for DAV132, the first product protecting against the clinical consequences of intestinal microbiota dysbiosis
Clinical & Manufacturing

Da Volterra announces positive Phase 2 results for DAV132, the first product protecting against the clinical consequences of intestinal microbiota dysbiosis

FEB 17, 2020
Dr. Georg Gerber on the computational approaches that will enable new microbiome diagnostics and therapeutics
Editor's Choice

Dr. Georg Gerber on the computational approaches that will enable new microbiome diagnostics and therapeutics

FEB 12, 2020
Rebiotix, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660
Clinical & Manufacturing

Rebiotix, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660

FEB 10, 2020
TargEDys® Announces Positive Results of Its Clinical Trial With Its Probiotic Strain Weight Loss
Biotics and Supplements

TargEDys® Announces Positive Results of Its Clinical Trial With Its Probiotic Strain Weight Loss

FEB 10, 2020
MaaT Pharma Announces €18 Million Series B Financing Round
Finance

MaaT Pharma Announces €18 Million Series B Financing Round

FEB 5, 2020
Non-living microbiome therapeutics: European organisation strives to bring regulatory challenges for these drug products into focus
Editor's Choice

Non-living microbiome therapeutics: European organisation strives to bring regulatory challenges for these drug products into focus

FEB 3, 2020
Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development
Finance

Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development

JAN 31, 2020
Study provides first look at sperm microbiome using RNA sequencing
Pharma & Human Health

Study provides first look at sperm microbiome using RNA sequencing

JAN 31, 2020
Stopping Climate Change with Prehistoric Microbes
Phytobiome & Environment

Stopping Climate Change with Prehistoric Microbes

JAN 24, 2020